SCHEMBL25002650

SCHEMBL25002650

COc1cc(N2CCC3(CCN(CCF)CC3)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)C)n1

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25001564 0.94 EGFR (0.47) EGFR
SCHEMBL25001795 0.93 EGFR (0.45) EGFR
SCHEMBL25001831 0.93 EGFR (0.51) EGFR
SCHEMBL25002785 0.92 EGFR (0.47) EGFR
SCHEMBL25001595 0.91 EGFR (0.48) EGFR
SCHEMBL25002857 0.91 EGFR (0.46) EGFR
SCHEMBL25001802 0.90 EGFR (0.59) EGFR
SCHEMBL25001481 0.89 EGFR (0.48) EGFR
SCHEMBL25001565 0.89 EGFR (0.48) EGFR
SCHEMBL25001947 0.89 EGFR (0.54) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback